Recently, PTEN has been shown to play an important role in the composition and function of the tumor microenvironment; therefore, loss of PTEN may impact response to immunotherapy.41 Large clinical trials are needed to determine the most relevant PTEN assessment based on treatment response. This evidence concerns the gene PTEN and neoplasm.